enderView.ai
Sign InStart free
ClosedSuppliesEuropeanOpenGreen

DKT (DTaP) vaccines 2024

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Open · 1 lots · 360503
Type
Supplies
33651600
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The National Institute for Public Health and the Environment (RIVM) is requesting offers for DTaP vaccines (Diphtheria, Tetanus, acellular Pertussis) via an open procedure in 2024. The objective is to supply the national vaccination programme. Suppliers must comply with EU regulations, GMP certification, and RIVM-specific quality and safety standards. The procurement includes supply, logistics, and post-delivery support. The procedure is public, without prior selection, and focuses on transparent pricing and quality.

Supplies · Open · European procedure

Sustainability countsEuropean
Contracting authority
Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
Contract type
Supplies
Open
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
33651600
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderGreen / SPPDTaPvaccinespublic procurement

01What is being requested

The National Institute for Public Health and the Environment (RIVM) is requesting offers for DTaP vaccines (Diphtheria, Tetanus, acellular Pertussis) via an open procedure in 2024. The objective is to supply the national vaccination programme. Suppliers must comply with EU regulations, GMP certification, and RIVM-specific quality and safety standards. The procurement includes supply, logistics, and post-delivery support. The procedure is public, without prior selection, and focuses on transparent pricing and quality.

This Invitation To Tender (ITT) concerns the public procurement of DTaP (Diphtheria, Tetanus, acellular Pertussis) vaccines and is for the benefit of The State of the Netherlands - National Institute for Public Health and the Environment (RIVM), and has Mercell S2C number T122190.

33651600Supplies
1DKT (DTaP) vaccines 2024€1

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME786×
2Mediost B.V.SME7414×
3Siemens Healthineers Nederland B.V.SME7413×
4Johnson & Johnson Medical B.V.SME7316×
5King Nederland B.V.SME7310×
6Fuego Tiel B.V.SME709×

05Legal themes that may be relevant here

06Frequently asked questions

What is the subject of this tender?
This tender concerns the public procurement of DTaP vaccines (Diphtheria, Tetanus, acellular Pertussis) for the benefit of the National Institute for Public Health and the Environment (RIVM).
What is the Mercell S2C number of this contract?
The tender for the DTaP vaccines has Mercell S2C number T122190.
For what purpose are the DTaP vaccines being procured?
The procurement of the DTaP vaccines is intended for the supply of the national vaccination programme.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528